COSA Annual Scientific Meeting

This theme reflects how far cancer care has evolved; from a one-size-fits-all rigid approach, to care that is increasingly tailored to the individual, across the entire cancer journey.

The disease theme will have a strong focus on lung cancers, alongside sessions addressing head and neck cancers, early-onset cancers such as colorectal cancer, and brain cancer, including both primary and metastatic disease. As always, equity will be embedded throughout the program, reflecting COSA’s ongoing commitment to improving outcomes for all people affected by cancer.

It has been almost a decade since the COSA ASM was held in Sydney, so we are excited to bring it back to showcase the remarkable advances that have transformed cancer care over this time, including the molecular biomarker realm and the evolution of novel transformative therapeutics.

Australia has developed deep expertise across clinical care, research and clinical trials, implementation and policy, and the program will highlight this local leadership alongside contributions from international experts in the fields of drug development, precision oncology, pharmacogenomics and palliative and supportive care.